Subdividing atypical glandular cells of undetermined significance according to the Australian modified Bethesda system: Analysis of outcomes

Cancer

Volumn 90, Issue 2, 2000, Pages 87-95

  Roberts, Jennifer M ^a   Thurloe, Julia K ^a   Bowditch, Ronald C ^a   Laverty, Colin R ^a  

^a NONE

Author keywords

Adenocarcinoma in situ; Atypical glandular cells of undetermined significance; Papanicolaou (Pap) smear; The Bethesda system

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER RISK; CARCINOMA IN SITU; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE ENDOCERVIX;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034712764     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000425)90:2<87::AID-CNCR3>3.0.CO;2-O     Document Type: Article

References (25)

1. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer (Cancer Cytopathol) 1999;87:48-55.
2. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer Verlag, 1994.
3. ASCCP Practice Committee. ASCCP practice guidelines: management of glandular abnormalities in the cervical smear. J Lower Genital Tract Dis 1997;1:41-5.
4. Zweizig S, Noller K, Reale F, Collis S, Resseguie L Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65: 314-8.
5. IAC Task Force on ASCUS and AGUS criteria. ASCUS and AGUS criteria. IAC Task Force summary. Acta Cytol 1998;42: 16-24.
6. Screening to prevent cervical cancer: guidelines for the management of women with screen detected abnormalities. Report by the National Health and Medical Research Council for the Organised Approach to Preventing Cancer of the Cervix. Canberra: Commonwealth Department of Human Services and Health, Australian Government Printing Service, 1994.
7. Ayer B, Pacey F, Greenberg M, Bousfield L. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. 1. Adenocarcinoma in situ. Acta Cytol 1987; 31:397-411.
8. Valente PT, Schantz HD. The diagnosis of glandular abnormalities in cervical smears. In: Schmidt WA, Katz RL, Miller TR, Silverman JF, Somrak TM. Cytopathology 1996. Volume 1. Chicago: ASCP Press, 1996:39-68.
9. Laverty CR, Farnsworth A, Thurloe J, Bowditch R. The reliability of a cytological prediction of cervical adenocarcinoma in situ. Aust N Z J Obstet Gynaecol 1988;28:307-12.
10. Laverty CR. Can the Pap smear diagnose adenocarcinoma precursors? The reliability and clinical significance of a cytological prediction of adenocarcinoma in situ. In: Chanen W, Atkinson K. 9th World Congress of Cervical Pathology & Colposcopy - Current status: future directions, Sydney, Australia, May 12-16, 1996. Bologna: Monduzzi Editore, 1996: 121-6.
11. Drijkoningen M, Meertens B, Lauweryns J. High grade squamous intraepithelial lesion (CIN3) with extension into the endocervical clefts: difficulty of cytologic differentiation from adenocarcinoma in situ. Acta Cytol 1996;40:889-94.
12. Burja IT, Thompson SK, Sawyer WL Jr., Shurbaji MS. Atypical glandular cells of undetermined significance on cervical smears: a study with cytohistologic correlation. Acta Cytol 1999;43:351-6.
13. Duska LR, Flynn CF, Chen A, Whall -Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998;91:278-82.
14. Eddy GL, Ural SH, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda System. Gynecol Oncol 1997;67:51-5.
15. Raab SS, Isacson C, Layfield LJ, Lenel JC, Slagel DD, Thomas PA. Atypical glandular cells of undetermined significance: cytologic criteria to separate clinically significant from benign lesions. Am J Clin Pathol 1995;104:574-82.
16. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system. Am J Obstet Gynecol 1997;177:1188-95.
17. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996; 63:14-8.
18. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
19. Ostor AG, Pagano R, Davoren RAM, Fortune DW, Chanen W, Rome R. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984;3:179-90.
20. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
21. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
22. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? the importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91: 973-6.
23. Manos MM, Kinney WK, Hurley LB, Sherman ME, ShiehNgai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-10.
24. Schoolland M, Sterrett GF, Knowles SAS, Mitchell KM, Kurinczuk JJ. The "inconclusive-possible high grade epithelial abnormality" category in Papanicolaou smear reporting. Cancer (Cancer Cytopathol) 1998;84:208-17.
25. Raab SS, Geisinger KR, Silverman JF, Thomas PA, Stanley MW. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance. Am J Clin Pathol 1998;110:653-9.